CVS Health (CVS) Expected to Announce Quarterly Earnings on Thursday

CVS Health (NYSE:CVS - Get Free Report) is expected to post its Q2 2025 quarterly earnings results before the market opens on Thursday, July 31st. Analysts expect the company to announce earnings of $1.45 per share and revenue of $94.87 billion for the quarter.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.31 earnings per share. On average, analysts expect CVS Health to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

CVS Health Price Performance

CVS Health stock traded up $1.92 during mid-day trading on Friday, hitting $60.67. The company's stock had a trading volume of 10,876,795 shares, compared to its average volume of 6,441,933. CVS Health has a twelve month low of $43.56 and a twelve month high of $72.51. The stock's fifty day moving average price is $64.61 and its two-hundred day moving average price is $63.53. The stock has a market capitalization of $76.75 billion, a P/E ratio of 14.48, a P/E/G ratio of 0.87 and a beta of 0.57. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.38%. The ex-dividend date of this dividend is Tuesday, July 22nd. CVS Health's dividend payout ratio is 63.48%.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.22% of the company's stock.

Analysts Set New Price Targets

Several research firms have issued reports on CVS. Mizuho boosted their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Royal Bank Of Canada upped their price target on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a research note on Monday, June 2nd. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, UBS Group decreased their price objective on CVS Health from $71.00 to $67.00 and set a "neutral" rating for the company in a research report on Tuesday, July 22nd. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $74.82.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.